INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 2 filers reported holding INARI MED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,396,287 | -35.1% | 51,931 | -42.3% | 0.05% | -27.8% |
| Q2 2023 | $5,236,612 | -6.1% | 90,069 | -0.3% | 0.07% | -21.7% |
| Q1 2023 | $5,576,110 | +32.1% | 90,316 | +36.0% | 0.09% | +16.5% |
| Q4 2022 | $4,220,638 | -36.9% | 66,404 | -27.9% | 0.08% | -32.5% |
| Q3 2022 | $6,694,000 | +9.6% | 92,154 | +2.6% | 0.12% | +7.3% |
| Q2 2022 | $6,105,000 | +111.9% | 89,794 | +182.5% | 0.11% | +303.7% |
| Q1 2022 | $2,881,000 | -71.7% | 31,789 | -71.5% | 0.03% | -53.4% |
| Q4 2021 | $10,179,000 | -42.1% | 111,524 | -48.6% | 0.06% | -36.3% |
| Q3 2021 | $17,590,000 | -15.5% | 216,897 | -2.9% | 0.09% | -10.8% |
| Q2 2021 | $20,827,000 | -12.6% | 223,277 | +0.3% | 0.10% | -20.3% |
| Q1 2021 | $23,816,000 | +34.8% | 222,581 | +10.0% | 0.13% | +45.5% |
| Q4 2020 | $17,671,000 | +78.2% | 202,436 | +40.9% | 0.09% | +44.3% |
| Q3 2020 | $9,918,000 | +0.8% | 143,699 | -29.3% | 0.06% | -20.8% |
| Q2 2020 | $9,839,000 | – | 203,123 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
| SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
| Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
| Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
| Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
| Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
| CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
| Birchview Capital, LP | 7,000 | $639,000 | 0.41% |